News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates
CureVac announces financial results for Q3 and first nine months of 2025, BioNTech transaction progresses, EMA clearance received for cancer therapy CVHNLC sqNSCLC -
-
-
-